Lymphocyte alloantigens of the horse. I. Serologic and genetic studies.
- Journal Article
- Research Support
- Non-U.S. Gov't
- Research Support
- U.S. Gov't
- P.H.S.
Summary
This research aims to understand the genetic system that controls the lymphocyte alloantigens in horses, exploring its importance in immunological responses. The study employs a high number of sera screened for alloantibody using lymphocytes from various unrelated horses, establishing a connection between the Equine Leukocyte Antigen (ELA) and the maternal immunological response to fetal histocompatibility antigens in horses.
Details of the Research
The study delves deeper into the following areas:
- The research describes the genetic system controlling the lymphocyte alloantigens in horses, pointing to the significance of these alloantigens in the overall immune response of horses. Alloantigens are proteins present on the cells of a particular species that can provoke an immune response in a different member of the same species.
- The study utilized the alloantisera to paternal histocompatibility antigens that get prompted as a result of pregnancy in mares. This was used in the antibody-mediated and complement-dependent microcytotoxicity assays to identify 15 ELA specificities using cluster analysis. The microcytotoxicity assay is designed to test the toxicity of substances on microscopic organisms, and in this context, it was used to analyze the interaction between antibodies and equine lymphocytes.
- A total number of 369 sera were collected and screened for alloantibody using the lymphocytes from ten unrelated horses. Of these, 83% were found to have an antibody to lymphocyte alloantigens. After the initial cluster analysis, 120 of the most distinguishing sera were tested against further 400 horses.
- The study also successfully identified the phenotypic distribution of the ELA antigens in 304 arbitrarily selected horses, which showed that 13 of the alloantigens acted as members of a single allelic series, provisionally named locus ELA-A. These accounted for about 90% of the genes at this locus.
- It also noticed a remarkable difference in frequencies of the ELA-A specificities among the Standardbred and Thoroughbred breeds of horses. Rare ‘blank’ alleles suggested by the estimated cumulative gene frequency of known alleles at ELA-A were identified in informative families.
- The researchers posited that the ELA system might be the Major Histocompatibility Complex of the horse, although the evidence is not yet conclusive. The frequency of sensitization to ELA antigens in pregnant mares indicates the potential of the horse as a model for research on the maternal immunological response to fetal histocompatibility antigens.
This study provides useful information regarding the immune mechanisms in horses and might be instrumental in understanding interspecies immunological responses. Further research can explore the possibilities of the ELA system being the Major Histocompatibility complex in horses and delve deeper into inter-breed differences in ELA-A specificities.
Cite This Article
Publication
Researcher Affiliations
MeSH Terms
- Animals
- Antilymphocyte Serum / immunology
- Cytotoxicity Tests, Immunologic
- Epitopes / genetics
- Female
- Gene Frequency
- Histocompatibility Antigens / genetics
- Histocompatibility Antigens / immunology
- Horses / genetics
- Horses / immunology
- Isoantigens / genetics
- Isoantigens / immunology
- Lymphocytes / immunology
- Male
- Phenotype
- Pregnancy
Grant Funding
- HD-15799 / NICHD NIH HHS
Citations
This article has been cited 15 times.- Antczak DF, Allen WRT. Placentation in Equids.. Adv Anat Embryol Cell Biol 2021;234:91-128.
- Miller D, Tallmadge RL, Binns M, Zhu B, Mohamoud YA, Ahmed A, Brooks SA, Antczak DF. Polymorphism at expressed DQ and DR loci in five common equine MHC haplotypes.. Immunogenetics 2017 Mar;69(3):145-156.
- Berglund AK, Schnabel LV. Allogeneic major histocompatibility complex-mismatched equine bone marrow-derived mesenchymal stem cells are targeted for death by cytotoxic anti-major histocompatibility complex antibodies.. Equine Vet J 2017 Jul;49(4):539-544.
- Brosnahan MM, Silvela EJ, Crumb J, Miller DC, Erb HN, Antczak DF. Ectopic Trophoblast Allografts in the Horse Resist Destruction by Secondary Immune Responses.. Biol Reprod 2016 Dec;95(6):135.
- Bergmann T, Moore C, Sidney J, Miller D, Tallmadge R, Harman RM, Oseroff C, Wriston A, Shabanowitz J, Hunt DF, Osterrieder N, Peters B, Antczak DF, Sette A. The common equine class I molecule Eqca-1*00101 (ELA-A3.1) is characterized by narrow peptide binding and T cell epitope repertoires.. Immunogenetics 2015 Nov;67(11-12):675-89.
- Pezzanite LM, Fortier LA, Antczak DF, Cassano JM, Brosnahan MM, Miller D, Schnabel LV. Equine allogeneic bone marrow-derived mesenchymal stromal cells elicit antibody responses in vivo.. Stem Cell Res Ther 2015 Apr 12;6(1):54.
- Antczak DF, de Mestre AM, Wilsher S, Allen WR. The equine endometrial cup reaction: a fetomaternal signal of significance.. Annu Rev Anim Biosci 2013 Jan;1:419-42.
- Brosnahan MM, Miller DC, Adams M, Antczak DF. IL-22 is expressed by the invasive trophoblast of the equine (Equus caballus) chorionic girdle.. J Immunol 2012 May 1;188(9):4181-7.
- Tallmadge RL, Campbell JA, Miller DC, Antczak DF. Analysis of MHC class I genes across horse MHC haplotypes.. Immunogenetics 2010 Mar;62(3):159-72.
- de Mestre A, Noronha L, Wagner B, Antczak DF. Split immunological tolerance to trophoblast.. Int J Dev Biol 2010;54(2-3):445-55.
- de Mestre AM, Miller D, Roberson MS, Liford J, Chizmar LC, McLaughlin KE, Antczak DF. Glial cells missing homologue 1 is induced in differentiating equine chorionic girdle trophoblast cells.. Biol Reprod 2009 Feb;80(2):227-34.
- Adams AP, Oriol JG, Campbell RE, Oppenheim YC, Allen WR, Antczak DF. The effect of skin allografting on the equine endometrial cup reaction.. Theriogenology 2007 Jul 15;68(2):237-47.
- Tallmadge RL, Lear TL, Antczak DF. Genomic characterization of MHC class I genes of the horse.. Immunogenetics 2005 Nov;57(10):763-74.
- Lew AM, Bailey E, Valas RB, Coligan J. The gene encoding the equine soluble class I molecule is linked to the horse MHC.. Immunogenetics 1986;24(2):128-30.
- Meredith D, Elser AH, Wolf B, Soma LR, Donawick WJ, Lazary S. Equine leukocyte antigens: relationships with sarcoid tumors and laminitis in two pure breeds.. Immunogenetics 1986;23(4):221-5.